These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6174446)

  • 81. Clinical significance of serum hepatocyte growth factor levels in liver diseases.
    Hioki O; Watanabe A; Minemura M; Tsuchida T
    J Med; 1993; 24(1):35-46. PubMed ID: 7684768
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Studies of 125I alpha-fetoprotein determination with a double antibody technic (2)].
    Demura H; Jibiki K; Sugimura E; Miyawaki A; Kozeki C
    Horumon To Rinsho; 1978 Oct; 26(10):1077-9. PubMed ID: 83209
    [No Abstract]   [Full Text] [Related]  

  • 84. Detection of alpha 1 feto protein in liver disorders and certain gastro-intestinal tract cancers by counter-immuno-electrophoresis.
    Sathe SB; Taskar SP; Patel CV
    Indian J Cancer; 1978 Sep; 15(3):35-6. PubMed ID: 93572
    [No Abstract]   [Full Text] [Related]  

  • 85. [Regression of hepatocellular carcinoma under Tamoxifen: report of one case and review of the literature].
    Macaigne G; Auriault ML; Boivin JF; Cheaib S; Chayette C; Deplus R
    Gastroenterol Clin Biol; 2002 Dec; 26(12):1165-7. PubMed ID: 12520204
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Incidence rate and geographic distribution of hepatoma in Burundi.
    Kocheleff P; Carteron B; Constant JL; Bedere C; Perrin J; Kabondo P; Chiron JP
    Ann Soc Belg Med Trop; 1984 Sep; 64(3):299-307. PubMed ID: 6210064
    [No Abstract]   [Full Text] [Related]  

  • 88. Serum alpha-fetoprotein in nonneoplastic liver diseases.
    Bloomer JR
    Dig Dis Sci; 1980 Apr; 25(4):241-2. PubMed ID: 6156062
    [No Abstract]   [Full Text] [Related]  

  • 89. Rivanol precipitation technique for the detection of alpha-feto-protein.
    Mody NJ; Vogel CL; Patel IR; McIntire KR
    J Lab Clin Med; 1972 Jul; 80(1):125-33. PubMed ID: 4338276
    [No Abstract]   [Full Text] [Related]  

  • 90. [Early diagnosis of the hepatocellular carcinoma (author's transl)].
    Imaeda T; Suzuki M; Yanagawa S; Doi H
    Rinsho Hoshasen; 1979 Mar; 24(3):423-4. PubMed ID: 94932
    [No Abstract]   [Full Text] [Related]  

  • 91. [Clinical contribution to the study of X (Lp-X) lipoprotein].
    Garijo JM; Casais M; Vidal E; Otero JL
    Rev Clin Esp; 1975 Jun; 137(5):407-11. PubMed ID: 167404
    [No Abstract]   [Full Text] [Related]  

  • 92. Fucosylation of alpha-fetoprotein in hepatocellular carcinomas.
    Buamah PK; Cornell C; Cassells-Smith AJ; Harris AL
    Lancet; 1986 Apr; 1(8486):922-3. PubMed ID: 2421123
    [No Abstract]   [Full Text] [Related]  

  • 93. The present and the future for cancer testing by alpha-fetoprotein. A review.
    Tatarinov YS
    J Maine Med Assoc; 1979 Jan; 70(1):30-6. PubMed ID: 84846
    [No Abstract]   [Full Text] [Related]  

  • 94. [Supplemental study of malignant metaplasia in a patient with atrophic-hypertrophic changes in the liver and other organs].
    Lijec Vjesn; 1977 Sep; 99(9):575-6. PubMed ID: 74003
    [No Abstract]   [Full Text] [Related]  

  • 95. Serum alpha-feto protein (alpha-FP) and hepatoma in Rhodesian Africans.
    Seggie J; Gelfand M
    Trans R Soc Trop Med Hyg; 1975; 69(2):209-11. PubMed ID: 52210
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A complement fixation test for the detection of alpha-feto-protein in the diagnosis of primary liver cancer.
    Ching-Han L; Ming C
    Sci Sin; 1973 Nov; 16(4):612-6. PubMed ID: 4143426
    [No Abstract]   [Full Text] [Related]  

  • 97. [Serum ferritin in patients with hepatobiliary diseases (author's transl)].
    Uchiyama Y; Kanazawa S; Okuda K
    Rinsho Ketsueki; 1980 Aug; 21(8):1104-11. PubMed ID: 6160268
    [No Abstract]   [Full Text] [Related]  

  • 98. Hepatocellular Carcinoma in Paediatric Patients with Alagille Syndrome: Case Series and Review of Literature.
    Valamparampil JJ; Shanmugam N; Vij M; Reddy MS; Rela M
    J Gastrointest Cancer; 2020 Sep; 51(3):1047-1052. PubMed ID: 32180165
    [No Abstract]   [Full Text] [Related]  

  • 99. [Serum alpha-fetoproteins and cancer of the liver].
    Katz S; Rotemberg R
    Acta Gastroenterol Latinoam; 1972; 4(3):117-8. PubMed ID: 4348715
    [No Abstract]   [Full Text] [Related]  

  • 100. [The problem of immunochemical diagnosis of primary cancer of the liver].
    Assekrutova IV; Abelev GI; Kraevskiĭ NA; Perova SD; Perevodchikova NI
    Vestn Akad Med Nauk SSSR; 1967; 22(5):75-81. PubMed ID: 4174294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.